Loading clinical trials...
Loading clinical trials...
Clinical Relevance of Drug-drug Interactions (DDI) With the Currently Used Direct-acting Antiviral Therapy (DAA) Against Hepatitis C Virus (HCV)
Conditions
Locations
4
Spain
Unidad de Enfermedades Infecciosas Hospital Universitario Puerto Real.
Cadiz, Spain
Unidad de Enfermedades Infecciosas. Hospital Universitario Reina Sofía de Córdoba.
Córdoba, Spain
Unidad de Enfermedades Infecciosas. Hospital Universitario Juan Ramón Jiménez.
Huelva, Spain
Departamento de Medicina. Universidad de Sevilla Hospital Universitario Virgen de Valme.
Seville, Spain
Start Date
April 30, 2025
Primary Completion Date
December 1, 2025
Completion Date
March 1, 2026
Last Updated
April 15, 2025
NCT05992077
NCT05534633
NCT07412977
NCT07241962
NCT04134767
NCT04353986
Lead Sponsor
University of Seville
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions